P. Е. Коmarov
Research Subjects
P. Е. Коmarov has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- A. S. Navasardyan
Samara regional clinical hospital named after V.D. Seredavin
1 shared publication - E A Strebkova
Samara regional clinical hospital named after V.D. Seredavin
1 shared publication - E. A. Morozova
Samara regional clinical hospital named after V.D. Seredavin
1 shared publication - Olga V. Ushakova
Samara regional clinical hospital named after V.D. Seredavin
1 shared publication - P. V. Morinets
Samara regional clinical hospital named after V.D. Seredavin
1 shared publication S. I. Popova
Samara regional clinical hospital named after V.D. Seredavin
1 shared publication
Latest Publications
- Open Access
- 25 May 2021
- Published by Reaviz Medical University in Bulletin of the Medical Institute "REAVIZ" (REHABILITATION, DOCTOR AND HEALTH)
- Vol. 11 (2) , 5-10
Patients with CKD-5D and COVID infection. Individual organizational and clinical issues of therapy
New coronavirus infection (COVID-19) – a serious medical and social problem. Despite the achievement of certain successes in the treatment of patients with COVID-19, there is a need to develop special clinical and organizational approaches in patients with CKD who are on renal replacement therapy and are at special risk due to the course of the underlying disease and concomitant pathology. The article presents the experience of the Samara Regional Center of Nephrology and Dialysis of the Samara Regional Clinical Hospital named after V.D. Seredavin during the pandemic, as well as the features of the management of patients with stage 5 chronic kidney disease undergoing renal replacement therapy in the infectious department to provide MP to patients with COVID-19. Patients with CKD require increased attention, treatment of coronavirus infection (both specific and concomitant) should be carried out in full, while observing the regimens and dosage regimens of drugs and their combinations.
- 25 May 2021
- Published by Reaviz Medical University in Bulletin of the Medical Institute "REAVIZ" (REHABILITATION, DOCTOR AND HEALTH)
- Vol. 11 (2) , 5-10
Open AccessPatients with CKD-5D and COVID infection. Individual organizational and clinical issues of therapy
New coronavirus infection (COVID-19) – a serious medical and social problem. Despite the achievement of certain successes in the treatment of patients with COVID-19, there is a need to develop special clinical and organizational approaches in patients with CKD who are on renal replacement therapy and are at special risk due to the course of the underlying disease and concomitant pathology. The article presents the experience of the Samara Regional Center of Nephrology and Dialysis of the Samara Regional Clinical Hospital named after V.D. Seredavin during the pandemic, as well as the features of the management of patients with stage 5 chronic kidney disease undergoing renal replacement therapy in the infectious department to provide MP to patients with COVID-19. Patients with CKD require increased attention, treatment of coronavirus infection (both specific and concomitant) should be carried out in full, while observing the regimens and dosage regimens of drugs and their combinations.